Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VPT Patient Safety (VPS) Study
NCT07556107Phase 4Recruiting
- Sponsor
- Bassett Healthcare Network
- Start
- Aug 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin + tazobactam, meropenem in Infection, sepsis, sponsored by Bassett Healthcare Network. Started Aug 2026; status: recruiting.
02
Drugs
piperacillin + tazobactammeropenem
03
Conditions
Infectionsepsis
Beyond the preview
Go deeper on NCT07556107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07556107.